GLP-1 promotes insulin secretion
US$ 22.33
retatrutide vs tirzepatide efficacy safety Weight loss with retatrutide1, tirazepatide2, and semaglutide3 compared Retatrutide vs Tirzepatide — Key
Description
In a series of clinical trials (SURPASS 1-5) individuals with type 2 diabetes have shown reduction in both HbA1c (1.2 to 2.6%) and body weight (5.411.7 kg) (Nauck and D'Alessio 2022)
Providers are available 24/7 to make dosage changes or offer guidance
Zepbound was also approved in December 2024 for the treatment of moderate to severe obstructive sleep apnea (OSA) in adults with obesity [9]
But they deserve discussion because some offer genuine, if modest, benefits, and many people want non-pharmaceutical options as a starting point or complement
